Welcome to DrugBase!

Posted On: 31st December 2013 5:32 pm
Over the past few days we have been working on adding a new Out of Stock section, which aims to provide a list of all drugs currently unavailable on the market or in very short supply, as well as possible alternatives for those drugs.
Posted in: New Drugs
On:
26th January 2015 12:37 pm

The FDA approved Ofev (nintedanib) for the treatment of idiopathic pulmonary fibrosis (IPF). Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred over time.

Posted in: New Drugs
On:
25th January 2015 11:47 am

The FDA approved Esbriet (pirfenidone) for the treatment of idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become progressively scarred over time.

Posted In: News
On:
28th October 2014 2:23 am
Following a short period of shortage, the hyperthyroidism drug Eltroxin at concentrations of 50 and 100 mcg, is now again available at a price of 18 and 20 EGP, respectively; raised from its previous price of 7 and 9 EPG, respectively.

Posted In: General
On:
27th November 2014 1:09 pm

The development of antibiotics against life-threatening infections has always been seen as the most important achievement of modern medicine. The emergence, however, of multi-drug resistant (MDR) gram negative bacteria has drastically narrowed down the therapeutic options against them; a limitation which recently has led clinicians to reevaluate the clinical application of polymyxins, an old class of antibiotics.

Miscellaneous

Share This!

Respected Sites

drugs.com

rxlist.com

rxwiki.com

Need Help?

on-call support